Inhibition of GSK3 α/β impairs the progression of HNSCC.

Conclusion: GSK3α/β plays a crucial role in a variety of regulatory networks for HNSCC cancer progression as it drives proliferation or migration and thus GSK3 could serve as an interesting target for clinical drug development.
PMID: 29963225 [PubMed]

Source: Oncotarget - July 4, 2018 Category: Cancer & Oncology Tags: Oncotarget Source Type: research